RELAPSED MULTIPLE MYELOMA
Clinical trials for RELAPSED MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for RELAPSED MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for chinese patients with stubborn multiple myeloma
Disease control CompletedThis study tested a drug called elranatamab in 39 Chinese patients with multiple myeloma that stopped responding to standard treatments. The drug works by helping the body's immune system attack the cancer cells. The goal was to see if it is safe and can shrink or control the can…
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated May 26, 2026 11:47 UTC
-
New antibody therapy shows promise for Hard-to-Treat myeloma
Disease control CompletedThis study tested a new drug called REGN5459 in 43 people with multiple myeloma that had come back or stopped responding to other treatments. The drug is a bispecific antibody that helps the immune system attack cancer cells. The goal was to check safety and see if the drug could…
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase: PHASE1, PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 14:01 UTC